Endothelial nitric oxide synthase gene polymorphisms and erectile dysfunction in chronic pain

Area of Science:

• Genetics
• Andrology
• Pharmacogenomics

Background:

• Erectile dysfunction (ED) is a common condition, often associated with chronic pain.
• The role of endothelial nitric oxide synthase (eNOS) gene polymorphisms in treatment response is not fully understood.

Purpose of the Study:

• To investigate the association between eNOS gene polymorphisms (T786C, 4VNTR, G894T) and andrological treatment response in Spanish males with ED and chronic pain.
• To identify genetic markers that may predict treatment outcomes.

Main Methods:

• Genotyping of eNOS polymorphisms using quantitative polymerase chain reaction (qPCR) with Taqman probes.
• Recruitment of 105 Spanish male patients with ED and chronic pain.
• Statistical analysis using R software.

Main Results:

• A significant improvement in ED was observed in 76% of patients receiving andrological treatment (iPED5, testosterone, or combination).
• Patients with the T786C-CC genotype showed significantly better ED improvement.
• Multivariate regression identified age, opioid dose, and the T786C-C allele as factors influencing ED risk and severity.

Conclusions:

• The T786C polymorphism in the eNOS gene is a significant factor in the variable response to PDE5 inhibitors and testosterone therapy for erectile dysfunction in Spaniards.
• This genetic marker may aid in predicting treatment success for andrological conditions.